Xiaoning Sheng1, Haifeng Chen1,2,3, Pengfei Shao1, Ruomeng Qin1,2,3, Hui Zhao1,2,3, Yun Xu1,2,3, Feng Bai1,2,3. 1. Department of Neurology, Affiliated Drum Tower Hospital of Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Institute of Brain Science, Nanjing University, Nanjing, China. 2. Jiangsu Province Stroke Center for Diagnosis and Therapy, Nanjing, China. 3. Nanjing Neuropsychiatry Clinic Medical Center, Nanjing, China.
Abstract
BACKGROUND: Structural network alterations in Alzheimer's disease (AD) are related to worse cognitive impairment. The aim of this study was to quantify the alterations in gray matter associated with impaired cognition and their pathological biomarkers in AD-spectrum patients. METHODS: We extracted gray matter networks from 3D-T1 magnetic resonance imaging scans, and a graph theory analysis was used to explore alterations in the network metrics in 34 healthy controls, 70 mild cognitive impairment (MCI) patients, and 40 AD patients. Spearman correlation analysis was computed to investigate the relationships among network properties, neuropsychological performance, and cerebrospinal fluid pathological biomarkers (i.e., Aβ, t-tau, and p-tau) in these subjects. RESULTS: AD-spectrum individuals demonstrated higher nodal properties and edge properties associated with impaired memory function, and lower amyloid-β or higher tau levels than the controls. Furthermore, these compensations at the brain regional level in AD-spectrum patients were mainly in the medial temporal lobe; however, the compensation at the whole-brain network level gradually extended from the frontal lobe to become widely distributed throughout the cortex with the progression of AD. CONCLUSION: The findings provide insight into the alterations in the gray matter network related to impaired cognition and pathological biomarkers in the progression of AD. The possibility of compensation was detected in the structural networks in AD-spectrum patients; the compensatory patterns at regional and whole-brain levels were different and the clinical significance was highlighted.
BACKGROUND: Structural network alterations in Alzheimer's disease (AD) are related to worse cognitive impairment. The aim of this study was to quantify the alterations in gray matter associated with impaired cognition and their pathological biomarkers in AD-spectrum patients. METHODS: We extracted gray matter networks from 3D-T1 magnetic resonance imaging scans, and a graph theory analysis was used to explore alterations in the network metrics in 34 healthy controls, 70 mild cognitive impairment (MCI) patients, and 40 AD patients. Spearman correlation analysis was computed to investigate the relationships among network properties, neuropsychological performance, and cerebrospinal fluid pathological biomarkers (i.e., Aβ, t-tau, and p-tau) in these subjects. RESULTS: AD-spectrum individuals demonstrated higher nodal properties and edge properties associated with impaired memory function, and lower amyloid-β or higher tau levels than the controls. Furthermore, these compensations at the brain regional level in AD-spectrum patients were mainly in the medial temporal lobe; however, the compensation at the whole-brain network level gradually extended from the frontal lobe to become widely distributed throughout the cortex with the progression of AD. CONCLUSION: The findings provide insight into the alterations in the gray matter network related to impaired cognition and pathological biomarkers in the progression of AD. The possibility of compensation was detected in the structural networks in AD-spectrum patients; the compensatory patterns at regional and whole-brain levels were different and the clinical significance was highlighted.
Authors: Rachel F Buckley; Bernard Hanseeuw; Aaron P Schultz; Patrizia Vannini; Sarah L Aghjayan; Michael J Properzi; Jonathan D Jackson; Elizabeth C Mormino; Dorene M Rentz; Reisa A Sperling; Keith A Johnson; Rebecca E Amariglio Journal: JAMA Neurol Date: 2017-12-01 Impact factor: 18.302
Authors: Betty M Tijms; Mara Ten Kate; Alle Meije Wink; Pieter Jelle Visser; Mirian Ecay; Montserrat Clerigue; Ainara Estanga; Maite Garcia Sebastian; Andrea Izagirre; Jorge Villanua; Pablo Martinez Lage; Wiesje M van der Flier; Philip Scheltens; Ernesto Sanz Arigita; Frederik Barkhof Journal: Neurobiol Aging Date: 2015-10-22 Impact factor: 4.673
Authors: Sang Wook Yoo; Cheol E Han; Joseph S Shin; Sang Won Seo; Duk L Na; Marcus Kaiser; Yong Jeong; Joon-Kyung Seong Journal: Sci Rep Date: 2015-05-20 Impact factor: 4.379
Authors: Sara Llufriu; Eloy Martinez-Heras; Elisabeth Solana; Nuria Sola-Valls; Maria Sepulveda; Yolanda Blanco; Elena H Martinez-Lapiscina; Magi Andorra; Pablo Villoslada; Alberto Prats-Galino; Albert Saiz Journal: Neuroimage Clin Date: 2016-12-05 Impact factor: 4.881
Authors: Hua Zhang; Joseph Therriault; Min Su Kang; Kok Pin Ng; Tharick A Pascoal; Pedro Rosa-Neto; Serge Gauthier Journal: Alzheimers Res Ther Date: 2018-08-16 Impact factor: 6.982
Authors: Tingting Xu; Kathryn R Cullen; Bryon Mueller; Mindy W Schreiner; Kelvin O Lim; S Charles Schulz; Keshab K Parhi Journal: Neuroimage Clin Date: 2016-02-18 Impact factor: 4.881
Authors: Gerhard S Drenthen; Walter H Backes; Whitney M Freeze; Heidi I L Jacobs; Inge C M Verheggen; Martin P J van Boxtel; Erik I Hoff; Frans R Verhey; Jacobus F A Jansen Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.160